Global Antibody Contract Manufacturing Market Size, Share, Trends, Industry Growth Factors | |
The Antibody Contract Manufacturing Global Market Report 2023, provides comprehensive information on the antibody contract manufacturing market across 60+ geographies in the seven regions - Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa for the 27 major global industries. The report covers a ten year historic period – 2010-2021, and a ten year forecast period – 2023-2032. Learn More On The Antibody Contract Manufacturing Market’s Growth: https://www.thebusinessresearchcompany.com/report/antibody-contract-manufacturing-global-market-report As per The Business Research Company’s Antibody Contract Manufacturing Global Market Report 2023, the global antibody contract manufacturing market is expected to grow from $11.18 billion in 2022 to $12.84 billion in 2023 at a compound annual growth rate (CAGR) of 14.82%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic. The war between these two countries has led to economic sanctions on multiple countries, surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and resulted in increased interest rates affecting many markets across the globe. The antibody contract manufacturing market is expected to reach $21.79 billion in 2027 at a CAGR of 14.13%. Get A Free Sample Of The Report (Includes Graphs And Tables): https://www.thebusinessresearchcompany.com/sample_request?id=12665&type=smp Technological advancements are a key trend gaining popularity in the antibody contract manufacturing market. Major companies operating in the antibody contract manufacturing market are adopting new technologies to sustain their position in the market. For instance, in October 2021, Merck KGaA, a Germany-based science and technology company, introduced ChetoSensar, an innovative technology aimed at addressing solubility challenges in antibody-drug conjugates (ADCs). Merck KGaA intends to leverage their expertise in contract development manufacturing for the development of next-generation antibody-drug conjugates and improve the effectiveness of high-potency active pharmaceutical ingredients (HPAPIs) by enhancing the solubility of these compounds through the innovative ChetoSensar technology. The antibody contract manufacturing market is segmented: 1) By Product: Monoclonal Antibodies, Polyclonal Antibodies, Other Products 2) By Source: Mammalian, Microbial 3) Scale Of Operation: Preclinical, Clinical, Commercial 4) By End-User: Biopharmaceutical Companies, Research Laboratories, Other End Users North America was the largest region in the antibody contract manufacturing market in 2022. The table of contents in TBRC’s antibody contract manufacturing market report includes: 1. Executive Summary 2. Antibody Contract Manufacturing Market Characteristics 3. Antibody Contract Manufacturing Market Trends And Strategies 4. Antibody Contract Manufacturing Market - Macro Economic Scenario 5. Global Antibody Contract Manufacturing Market Size and Growth ...... 32. Global Antibody Contract Manufacturing Market Competitive Benchmarking 33. Global Antibody Contract Manufacturing Market Competitive Dashboard 34. Key Mergers And Acquisitions In The Antibody Contract Manufacturing Market 35. Antibody Contract Manufacturing Market Future Outlook and Potential Analysis 36. Appendix | |
| Target State: All States Target City : All Cities Last Update : Nov 18, 2023 9:10 AM Number of Views: 54 | Item Owner : TBRC Contact Email: (None) Contact Phone: (None) |
| Friendly reminder: Click here to read some tips. | |